Evidence map›Paper›PMID 42011005›Full record

ArticleJournal of chemical theory and computation2026

Developing and Benchmarking Sage 2.3.0 with the AshGC Neural Network Charge Model.

Lily Wang, Irfan Alibay, Pavan Kumar Behara, Simon Boothroyd, Chapin E Cavender, Joshua T Horton, Alexandra R McIsaac, Ashley Mitchell, Barbara Morales, Matthew W Thompson and 8 more

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Reparameterization of the Amber RNA Force Field Non-Bonded Terms.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lily WangOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.ORCID 0000-0002-6095-6704
Irfan AlibayOpen Free Energy, Open Molecular Software Foundation, Davis, California95616, United States.ORCID 0000-0001-5787-9130
Pavan Kumar BeharaCenter for Neurotherapeutics, University of California, Irvine, California92697, United States.ORCID 0000-0001-6583-2148
Simon BoothroydBoothroyd Scientific Consulting Ltd., LondonWC2H 9JQ, U.K.ORCID 0000-0002-3456-1872
Chapin E CavenderSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California92093, United States.ORCID 0000-0002-5899-7953
Joshua T HortonSchool of Natural and Environmental Sciences, Newcastle University, Newcastle upon TyneNE1 7RU, U.K.
Alexandra R McIsaacOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.
Ashley MitchellOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.
Barbara MoralesDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado80305, United States.
Matthew W ThompsonOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.
Jeffrey R WagnerOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.
Brent R WestbrookOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.
Christopher I BaylyOpen Molecular Software Foundation, Davis, California95616, United States.
John D ChoderaComputational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York10065, United States.ORCID 0000-0003-0542-119X
Daniel J ColeSchool of Natural and Environmental Sciences, Newcastle University, Newcastle upon TyneNE1 7RU, U.K.
James R B EastwoodOpen Force Field, Open Molecular Software Foundation, Davis, California95616, United States.ORCID 0000-0003-3895-5227
Michael R ShirtsDepartment of Chemical and Biological Engineering, University of Colorado Boulder, Boulder, Colorado80305, United States.ORCID 0000-0003-3249-1097
David L MobleyDepartment of Pharmaceutical Sciences, University of California, Irvine, California92697, United States.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Open data-driven infrastructure for building biomolecular force fields for predictive biophysics and drug designR01GM132386 · NIGMS · UNIVERSITY OF COLORADO · PI SHIRTS, MICHAEL R · 2020 to 2023
$3.1M
Accelerating drug discovery via ML-guided iterative design and optimizationR35GM148236 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI David Lowell Mobley · 2023 to 2026
$2.2M
Teaching free energy calculations to learnR35GM152017 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI John Damon Chodera · 2024 to 2026
$1.6M
Computational tools for new pharmaceutical paradigmsR35GM158359 · NIGMS · UNIVERSITY OF COLORADO · PI Michael R Shirts · 2025 to 2026
$810k
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM132386NIGMS NIH HHS R35 GM148236NIGMS NIH HHS R35 GM152017NIGMS NIH HHS R35 GM158359
6 · The paper itself

Abstract

Partial atomic charges are a fundamental component underlying classical molecular simulations, but assigning charges remains a computational bottleneck; many common methods rely on quantum mechanical calculations that scale poorly with molecular size and are sensitive to the choice of conformer geometry. We introduce Open Force Field (OpenFF) AshGC, a new graph convolutional neural network charge model, as well as the Sage 2.3.0 small molecule force field for drug-like molecules parametrized to be consistent with AshGC. AshGC is designed to efficiently produce conformer-independent charges of semiempirical quality at linear cost for molecules of all sizes, from small molecules to macromolecules. AshGC largely generates charges within the range of other accepted AM1-BCC backends such as OpenEye's oequacpac and AmberTools' sqm, deviating most in smaller molecules between 4 and 9 heavy atoms, in negatively charged molecules, and areas of chemistry underrepresented in the training set, such as particular sulfur- and phosphorus-containing functional groups. We further present the development and performance of Sage 2.3.0, which has both Lennard-Jones and valence parameters that are retrained to be consistent with neural network charges for the first time. Benchmarks spanning gas-phase geometry optimization through protein-ligand binding free energies show Sage 2.3.0 performs comparably to earlier Sage releases, with modest improvements in condensed-phase properties and a slight decrease in nonaqueous solvation free energy accuracy. As with other OpenFF force fields, Sage 2.3.0 was validated in protein-ligand benchmarks to be compatible with Amber protein force fields. All data are publicly available, along with scripts and environments for reproducing the training and benchmarking of AshGC and Sage 2.3.0 at https://github.com/openforcefield/ashgc-v1.0-fit and https://github.com/openforcefield/ash-sage-rc2 respectively.

Indexed as

Neural Networks, ComputerBenchmarkingGraph Neural NetworksMolecular Dynamics SimulationQuantum Theory

Identifiers

PMID42011005
PMCPMC13173527

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.